90 related articles for article (PubMed ID: 11834253)
1. Venodilator action of an organotransition-metal nitrosyl complex.
Poon KS; Pang CC
Eur J Pharmacol; 2002 Feb; 436(1-2):107-10. PubMed ID: 11834253
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator effects of organotransition-metal nitrosyl complexes, novel nitric oxide donors.
Wang YX; Legzdins P; Poon JS; Pang CC
J Cardiovasc Pharmacol; 2000 Jan; 35(1):73-7. PubMed ID: 10630735
[TBL] [Abstract][Full Text] [Related]
3. Effects of vasodilator drugs on venous tone in conscious rats.
D'Oyley HM; Tabrizchi R; Pang CC
Eur J Pharmacol; 1989 Mar; 162(2):337-44. PubMed ID: 2498109
[TBL] [Abstract][Full Text] [Related]
4. Effect of nociceptin/orphanin FQ on venous tone in conscious rats.
Abdelrahman AM; Pang CC
Eur J Pharmacol; 2002 Nov; 455(2-3):143-7. PubMed ID: 12445580
[TBL] [Abstract][Full Text] [Related]
5. Effects of pinacidil on arterial and venous resistances and mean circulatory filling pressure in rats.
Waite RP; Lim SL; Pang CC
Br J Pharmacol; 1995 Oct; 116(4):2322-6. PubMed ID: 8564267
[TBL] [Abstract][Full Text] [Related]
6. T-1032, a novel specific phosphodiesterase type 5 inhibitor, increases venous compliance in anesthetized rats.
Inoue H; Yano K; Ikeo T; Noto T; Kikkawa K
Eur J Pharmacol; 2001 Jun; 422(1-3):109-14. PubMed ID: 11430921
[TBL] [Abstract][Full Text] [Related]
7. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo.
Ng SS; Pang CC
Br J Pharmacol; 1998 Nov; 125(6):1247-51. PubMed ID: 9863653
[TBL] [Abstract][Full Text] [Related]
8. Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats.
Abdelrahman AM; Lin Lim S; Pang CC
Eur J Pharmacol; 2005 Mar; 510(1-2):107-11. PubMed ID: 15740730
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin gene-related peptide is a venous dilator in conscious rats.
Abdelrahman A; Pang CC
Eur J Pharmacol; 1992 Jul; 217(2-3):185-9. PubMed ID: 1358633
[TBL] [Abstract][Full Text] [Related]
10. Effects of MCI-154, a novel cardiotonic agent, on mean circulatory filling pressure in anesthetized dogs.
Satoh N; Abe Y; Kitada Y; Narimatsu A; Tobe A
Eur J Pharmacol; 1990 Jan; 175(3):317-22. PubMed ID: 2108868
[TBL] [Abstract][Full Text] [Related]
11. Effect of substance P on venous tone in conscious rats.
Abdelrahman AM; Pang CC
J Cardiovasc Pharmacol; 2005 Jan; 45(1):49-52. PubMed ID: 15613979
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators in vivo.
Agvald P; Adding LC; Gustafsson LE; Persson MG
Eur J Pharmacol; 1999 Dec; 385(2-3):137-45. PubMed ID: 10607869
[TBL] [Abstract][Full Text] [Related]
13. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats.
Cheng X; Cheng XS; Pang CC
Eur J Pharmacol; 2003 Jun; 470(3):171-5. PubMed ID: 12798955
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitric oxide and noradrenergic activation in the posterior hypothalamus on arterial pressure tolerance to nitroglycerin in rats.
Guettler DL; Ma SX
J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):98-106. PubMed ID: 18375750
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide donors dose-dependently reduce heart rate in rats against the background of blood pressure drop.
Nigmatullina RR; Nasyrova AG; Rakhmatullina FF
Bull Exp Biol Med; 2002 Jul; 134(1):32-5. PubMed ID: 12459863
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
Guo L; Tabrizchi R
Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
[TBL] [Abstract][Full Text] [Related]
17. Cerebral blood flow effects of the nitric oxide donor, nitroglycerin and its drug combinations in the non-human primate model.
Oliver DW; Dormehl IC
Arzneimittelforschung; 1999 Sep; 49(9):732-9. PubMed ID: 10514899
[TBL] [Abstract][Full Text] [Related]
18. In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist.
Ng SS; Pang CC
Br J Pharmacol; 2000 Mar; 129(5):853-8. PubMed ID: 10696081
[TBL] [Abstract][Full Text] [Related]
19. Zaprinast, a type V phosphodiesterase inhibitor, dilates capacitance vessels in anaesthetised rats.
Ng SS; Pang CC
Eur J Pharmacol; 1998 Jun; 351(3):323-8. PubMed ID: 9721024
[TBL] [Abstract][Full Text] [Related]
20. Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure.
Chien YW; Trippodo NC; Frohlich ED
Am J Physiol; 1989 Dec; 257(6 Pt 2):R1481-7. PubMed ID: 2532483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
